Concepedia
Statistics
Publications
23
Citations
2K
H-Index
18
Active since
2010
Affiliations
Moffitt Cancer Center(Current)
The University of Texas MD Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Massachusetts General Hospital
Celeste Bello is an author at Moffitt Cancer Center specializing in medicine, oncology, and hematologic oncology.
Publications per year
2010–2022
Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia
Jennifer R. Brown, John C. Byrd, Steven Coutré et al. · Blood · 2014 · 584 citations · Full text
Medicine, Oncology, Pharmacology +14
Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression
Eric D. Jacobsen, Jeff P. Sharman, Yasuhiro Oki et al. · Blood · 2015 · 302 citations · Full text
Life Sciences, Immunology, Immunotherapy +3
Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Richard T. Hoppe, Ranjana H. Advani, Weiyun Z. Ai et al. · Journal of the National Comprehensive Cancer Network · 2020 · 152 citations · Full text
Medicine, Oncology, Radiation Oncology +17
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
Richard T. Hoppe, Ranjana H. Advani, Weiyun Z. Ai et al. · Journal of the National Comprehensive Cancer Network · 2017 · 142 citations · Full text
Medicine, Oncology, Chemotherapy +16
Hodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines
Richard T. Hoppe, Ranjana H. Advani, Weiyun Z. Ai et al. · Journal of the National Comprehensive Cancer Network · 2012 · 99 citations · Full text
Medicine, Oncology, Radiology +17
1–5 of 23